Ultragenyx Pharmaceutical

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RARE and other ETFs, options, and stocks.

About RARE

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, engaged in the identification, acquisition, development and commercialization of novel products for the treatment of serious rare and ultra-rare genetic diseases. Its products include Mepsevii and Crysvita.

CEO

Emil D. Kakkis

CEOEmil D. Kakkis

Employees

1,119

Employees1,119

Headquarters

Novato, California

HeadquartersNovato, California

Founded

2010

Founded2010

Employees

1,119

Employees1,119

RARE Key Statistics

Market cap

2.88B

Market cap2.88B

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

592.24K

Average volume592.24K

High today

$42.07

High today$42.07

Low today

$40.34

Low today$40.34

Open price

$40.62

Open price$40.62

Volume

135.70K

Volume135.70K

52 Week high

$95.37

52 Week high$95.37

52 Week low

$39.75

52 Week low$39.75

Analyst ratings

71%

of 17 ratings

Buy

70.6%

Hold

29.4%

Sell

RARE Earnings

-$2.26

-$1.51

-$0.75

$0.00

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 1, After Hours

ActualExpected Nov 1, After Hours